BECAUSE OF THE WATER PERMEABILITY of the plasma membrane, perturbations of the osmotic equilibrium between the cell and its surrounding medium result in an immediate change in cell volume. To avoid the potential deleterious consequences of cell shrinkage or swelling, most eukaryotic cells have developed compensatory mechanisms that involve the activation of ion channels and/or transporters in the plasma membrane (for review, see Refs. 29, 31, 48, 49) . Hyposmotic stimulation of human intestine 407 epithelial cells leads to a rapid, transient increase in cell volume accompanied by the activation of distinct K ϩ -and Cl Ϫ -selective ion channels [i.e., regulatory volume decrease (RVD)] (55). The cell swelling-induced activation of the anion channels involved was found to require protein tyrosine phosphorylation and to depend on active p21 rho (43, 53) . Similar results were obtained with several other cell models, including vascular endothelial (5, 44) and neuronal cells (7, 8) , as well as plant cells (5) .
In a number of tissues, the release of small molecules such as taurine, betaine, and sorbitol contributes significantly to RVD. In excitable cells, these metabolites were found to be the major osmolytes released (41, 45) . Taurine especially has been implicated as an osmolyte involved in volume regulation (1, 10, 19) .
As is the case for volume-regulated anion channels (VRAC), the molecular identity of the organic osmolyte release pathway has not been elucidated yet (for review, see Ref. 42) . In a number of cell types, the efflux of organic osmolytes and anion conductance was regulated similarly, suggesting that a single release pathway is involved [i.e., volume-sensitive organic osmolyte and anion channel (VSOAC)] (16, 22-24, 40, 47) . In other cells, however, distinct pathways and/or transporters have been proposed (40, 46) . Indeed, in hippocampal slice preparations, at least two pathways for taurine release have been identified that differ in their kinetics of activation/inactivation and in their sensitivity for inhibitors (11) .
Using intestine 407 cells, we investigated the hypotonicityprovoked release pathway for organic osmolytes and compared its properties with those of VRAC activation. This cell line was particularly suitable for this study because no plasma membrane Cl Ϫ conductances other than VRAC, such as CFTR and voltage-sensitive or Ca 2ϩ -activated anion channels, are expressed (18, 55) . In this article, we report that osmotic swelling of intestine 407 cells results in massive release of taurine after a distinct lag period. The results indicate that the efflux of taurine is regulated independently of VRAC and uses a signaling pathway involving protein kinase C (PKC). Amino acid analysis. Medium and lysate fractions of 250 l were collected corresponding to 1-to 2-min stimuli. Taurine and ␤-alanine contents of cell lysates and incubation medium were analyzed by reverse-phase HPLC after pre-column derivatization with o-phthaldialdehyde as previously described (9) .
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Osmotic cell swelling-induced release of organic osmolytes.
Hyposmotic stimulation of intestine 407 cells not only triggers the activation of K ϩ -and Cl Ϫ -selective ionic channels but also activates an organic osmolyte release pathway, evidenced by the efflux of [ 3 H]taurine from isotope-loaded cells (Figs. 1 and 2) and by quantitating the taurine content of the incubation medium ( Fig. 1 ). The release of taurine started after a lag period of ϳ30 -60 s and lasted for at least 8 -12 min; thereafter a slightly elevated efflux remained (Fig. 1 ). During this period, the cellular content of taurine is reduced by 70% (Table 1) . In contrast, the 125 I Ϫ efflux displayed no apparent lag period ( Fig.  1) . Compared with the activation of volume-sensitive anion channels, the release of organic osmolytes developed considerably more slowly and lasted for a longer period (Fig. 1) . The organic osmolyte release pathway is not selective exclusively for taurine but also can conduct phosphocholine with similar kinetics, as determined using [ 3 H]choline-loaded cells ( Fig. 1 ), as well as ␤-alanine, a precursor of taurine (Table 1) .
To determine the threshold for activation, cultures of cells were treated with buffers of different osmolarity. As shown in Fig. 2 , the release of taurine required a reduction in osmolarity of the external medium to Յ225 mosmol/l, whereas saturation of the response was observed at an extracellular osmolarity of 100 mosmol/l. In contrast, hypotonicity-induced 125 I Ϫ efflux was already observed at 290 mosmol/l (i.e., a 10% reduction in osmolarity) and was maximal at 190 -225 mosmol/l (Fig. 2) . Taken together, the results indicate that the hypotonicityprovoked efflux of organic osmolytes acts as a relatively slow volume-correcting mechanism that starts only when the Cl Ϫ conductance has reached its maximum.
Organic release pathway does not involve VRAC. To date, the molecular nature of the organic anion release pathway has not been elucidated. In a number of cell models, the release of both Cl Ϫ and organic osmolytes seems to be mediated by the same channel protein; in other models, however, the release of Cl Ϫ and the release of taurine are apparently distinct processes. In an attempt to further discriminate between the release pathways for Cl Ϫ and taurine in intestine 407 cells, we also studied the effects of pharmacological inhibitors on anion conductance and the release of taurine.
Treating the cells with the purinoceptor antagonist and VRAC inhibitor suramin completely prevented the hypotonicity-induced release of taurine (Fig. 3) , suggesting that the same channel and/or transporter is involved. In contrast, however, DIDS and millimolar concentrations of extracellular ATP, which efficiently inhibit VRAC activation (57) , were unable to block the taurine efflux (Fig. 3) .
Previously, we (55) and others (32) demonstrated that activation of a tyrosine kinase, or inhibition of a phosphotyrosine phosphatase, is a prerequisite for the activation of volumesensitive anion channels. To investigate putative involvement of protein tyrosine phosphorylation in the regulation of the cell swelling-induced taurine release, we treated cultures of intes- tine 407 cells with the tyrosine kinase inhibitor genistein and with vanadate, an inhibitor of phosphotyrosine phosphatases. Unlike the activation of VRAC, the release of taurine and phosphocholine was neither increased by vanadate nor reduced after genistein treatment (Fig. 3) . In contrast, a small but significant increase of the efflux of taurine was observed in genistein-treated cells (Fig. 3) . These results suggest a pronounced difference in regulation between volume-sensitive Cl Ϫ channels and organic osmolyte release pathways. To further substantiate this notion, phosphatidylinositol 3-kinase (PtdIns 3-kinase) and p21 rho , both of which are critically involved in VRAC activation, were inhibited using respectively wortmannin or LY-294001 and Clostridium botulinum C3 exoenzyme. Again, wortmannin and LY-294001, as well as C3 exoenzyme treatment, did not affect the cell swellinginduced taurine efflux (Fig. 3) . Taken together, these results clearly indicate that the volume-sensitive taurine efflux in intestine 407 cells involves a different transport protein or channel and is regulated by a pathway independent of tyrosine kinases, PtdIns 3-kinase, and p21 rho . Role of organic anion or cation transporters. Movement of taurine and other organic osmolytes across the plasma membrane is mediated by at least four different transport proteins (OATs 1-3 and Taut; Refs. 15, 27, 51). To investigate whether these transporters contribute to the swelling-induced release of taurine and phosphocholine, cells were treated with established inhibitors of each of these transport systems. As shown in Table 2 , inhibitors of the OAT family of transporters, such as probenecid, methothrexate, fenobarbital, and tunicamycin, which lead to an intracellular retention of OATs, did not inhibit or only partially inhibited (20 -40% reduction) the hypotonic- Amount of taurine and ␤-alanine in cell lysates and bathing solution (8 min incubation) under isotonic and during hypo-osmotic (40%) shock. Data are expressed as means Ϯ SD for n ϭ 3. I-loaded (closed bars) cells were exposed to a hypotonic medium, and fractional isotope efflux was determined as described in MATERIALS AND METHODS. Cultures were treated with suramin (100 M, 5 min), ATP (5 mM, 5 min), wortmannin (10 nM, 1 h), LY-294002 (60 M, 1 h), genistein (200 M, 1 h), Na2VO3 (100 M, 5 min), Clostridium botulinum C3 exoenzyme (C3-exo; 50 g/ml, overnight incubation), and DIDS (50 M, 1 h). Data are expressed as the percent change in osmolyte efflux relative to the hypotonic control (mean Ϯ SD for n ϭ 3). *P Ͻ 0.05, significant difference from control. Cultures were loaded with [ 3 H]taurine, and the fractional efflux was determined as described in MATERIALS AND METHODS. Before the experiments, the cells were treated with the indicated inhibitors for 30 min, except for corticosterone and tunicamycin, which were added 16 h before the start of the experiment. Data are presented as percentages of the hypotonic control (mean Ϯ SD, n ϭ 3). *P Ͻ 0.05 indicates significant difference from control. OCT, organic cation transporter; OAT, organic anion transporter. ity-induced taurine efflux (20) . In contrast, decynium-22, cyanine-863, and quinidine, inhibitors of organic cation transporters (OCTs; Refs. 28, 59), strongly diminished the efflux of both taurine and phosphocholine (Table 2) . However, several OCT inhibitors (i.e., cimetidine, quinine, and verapamil) were found to be ineffective (Table 2 ). These combined pharmacological data argue against the concept of a single, "classical" organic osmolyte transporter (OAT or OCT) accounting for the cell swelling-induced release pathway.
PKC activation regulates the release of taurine. Among the cell models studied, considerable differences are observed in the regulation of taurine transport. Signaling pathways including PtdIns 3-kinase, calmodulin-dependent kinase, tyrosine kinases, and PKC have been reported. As described above, the release of taurine from hypotonicity-provoked intestine 407 cells did not require tyrosine kinase or PtdIns 3-kinase activity, nor did it depend on functional p21 In the presence of the specific PKC inhibitor GF109203X, marked inhibition of the cell swelling-induced taurine efflux was observed, and vice versa, activation of PKC by brief treatment of the cells with the phorbol ester PMA increased the response approximately twofold (Fig. 4) . The potentiation by PMA was fully reversed in the presence of GF109203X, indicating that PKC activation is involved. Notably, PMA did not increase basal taurine efflux (basal: 8 Ϯ 2%, PMA: 2 Ϯ 4% of hypotonic control). Prolonged treatment of the cultures with PMA in an attempt to downregulate PKC resulted in reduced basal efflux but only slightly affected the hypotonicity-induced efflux. Notably, the volume-sensitive anion efflux was not affected by PKC activation or inactivation (54) . Taken together, the results suggest the involvement of a Ca 2ϩ -insensitive PKC isoenzyme in the regulation of the cell swellinginduced release of organic osmolytes.
DISCUSSION
Most animal cells regulate their volume to avoid irreversible cellular damage or even cell death due to imbalances between intra-and extracellular osmolarity. We report a release pathway for organic osmolytes in intestine 407 epithelial cells, distinct from the compensatory anion efflux reported previously (53, 55, 57) and regulated by PKC. Hyposmotic release of organic osmolytes such as taurine, betaine, and inositol has been observed in many different cell models (2, 3, 12, 17, 25, 45, 46) . Unlike chloride ions, which can have additional effects on enzyme activity, membrane potential, and, in muscle and nerve cells, the generation of action potentials, these organic osmolytes do not affect other cellular functions, making them especially suitable for volume regulation (2, 13) . Stimulation of intestine 407 cells with mild hypotonic solutions (70 -90% tonicity) was found to promote anion efflux in the absence of effects on taurine efflux, whereas the efflux of taurine and phosphocholine was observed only after a more severe hyposmotic challenge (Ͻ70% tonicity; cf. Fig. 1 ). These results suggest that, in this cell type, activation of Cl Ϫ conductance is the first line of defense against osmotic cell swelling and that slower, more prolonged release of organic osmolytes serves as a last way out to prevent further cell swelling.
To date, at least two different mechanisms have been reported to be responsible for the release of organic osmolytes: a polyspecific one transporting both taurine and GABA and one selective for amino acids (25) . The latter involves VSOAC (4), a pathway facilitating the release of both Cl Ϫ and organic osmolytes (25, 26) and VSOC, a transporter of organic osmolytes only (11) . The molecular identity of these pathways remains to be established. Our experiments clearly showed a difference in time course as well as in the threshold for activation between the release of 125 I Ϫ and [ 3 H]taurine, suggesting that different pathways are involved. A differential sensitivity to DIDS of the Cl Ϫ and taurine release from HeLa cells has been reported, also pointing to the existence of separate pathways (50) . In contrast, the efflux of taurine was inhibited by chloride channel blockers, including DIDS and millimolar concentrations of ATP, in calf pulmonary endothelial (CPAE) cells (34) . In intestine 407 cells, however, DIDS treatment did not affect hypotonicity-induced taurine efflux (Fig. 3) . Recently, two different release pathways for taurine-a "fast" one and a "slow" one-have been observed in hippocampal brain slices, with the slow one being sensitive to DIDS (11) . It is therefore likely that only the fast release pathway is present in intestine 407 cells.
In an attempt to identify the transporters involved, cells were treated with a variety of OAT and OCT inhibitors. None of the OAT inhibitors tested were found to inhibit the release of taurine dramatically; however, a moderate (20 -40%) reduction in efflux was observed with some of the inhibitors tested. In contrast, taurine release was inhibited strongly by several OCT inhibitors but not by others. Because the taurine efflux was abolished almost completely after quinidine treatment, whereas the related and potent OCT inhibitor quinine (27) was ineffective, we think that a transport system other than the OCT is involved. This notion is supported by our observation that cimetidine and verapamil, inhibitors of all three OCT subtypes (58), did not reduce the hypotonicity-induced os- molyte efflux. However, we cannot completely rule out the possibility that a subset of transporters with different sensitivities for the inhibitors used may contribute to the observed organic osmolyte efflux.
In several selected cell models, the hypotonicity-provoked taurine release was found to be sensitive to inhibitors of protein tyrosine phosphorylation as well as to wortmannin, an inhibitor of PtdIns 3-kinase (11, 37) . In Intestine 407 cells, however, in clear contrast to the activation of VRAC (53, 55) , the release of taurine was found to be independent of tyrosine kinases and PtdIns 3-kinase and did not involve p21 rho . A similar low sensitivity to genistein has been reported for isolated rat supraoptic astrocytes (6) . Taken together, these results indicate not only that the release of taurine does not involve VRAC in intestine 407 cells but also that distinct signaling pathways are involved in the regulation of Cl Ϫ and taurine efflux (54) . An increase in intracellular free Ca 2ϩ has been reported to be involved in the activation of taurine efflux for several cell types, including erythroleukemia cells (21) , cultured rat astrocytes (33) , and rat cerebral cortex (30) . In astrocytes and cerebral granule cells, however, the hypotonicity-provoked taurine efflux was independent of [Ca 2ϩ ] i or required basal Ca 2ϩ levels (36, 38, 40 ] i is required, as observed previously for astrocytes (36) .
Brief treatment of intestine 407 cells with the phorbol ester PMA potentiated the cell swelling-induced taurine efflux, whereas addition of the PKC inhibitor GF109203X largely inhibited the response, suggesting a major role for PKC as an activator of this process. The PKC family of serine kinases consists of a large group of isoenzymes playing crucial roles in cellular signaling and involved in a variety of biological processes (for review, see Ref. 35) . The group can be divided into subgroups on behalf of their behavior and their protein sequence: the classical (␣, ␤, ␥), novel (␦, ⑀, , ), and atypical (, ) PKCs and the PKC-related kinases (PRK1, PRK2, PRK3). Whereas activation of PKC-␣, -␤, and -␥ requires binding of phosphatidylserine, both classical and novel PKCs are activated by the phorbol ester PMA. Because binding of phosphatidylserine occurs in a Ca 2ϩ -dependent manner, the permissive role of Ca 2ϩ (36) in the activation of hyposmotically triggered taurine efflux might be explained by the activation of these isoforms of PKC. In CPAE cells, however, the release of organic osmolytes was found to be independent of PKC (34) .
To summarize, the results of this study indicate that in intestine 407 cells, the hypotonicity-induced efflux of organic osmolytes is independent of VRAC and involves an activation pathway that includes PKC. These observations are not generally applicable, however, because in several other model systems, a close relationship between Cl Ϫ conductance and release of organic osmolytes has been established (16, 22-24, 40, 47) . Therefore, a definite answer to the question of whether the release pathways are the same or different awaits the molecular identification of the transporters involved.
